BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27815475)

  • 21. Prognostic indicators of metastatic bone disease in human breast cancer.
    Kamby C; Rasmussen BB; Kristensen B
    Cancer; 1991 Nov; 68(9):2045-50. PubMed ID: 1913553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interval Between Cancer Diagnosis and Radiotherapy - An Independent Prognostic Factor of Survival in Patients Irradiated for Bone Metastases from Kidney Cancer.
    Rades D; Haus R; Janssen S; Schild SE
    In Vivo; 2020; 34(2):767-770. PubMed ID: 32111782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Radiosensitivity of bone metastases from tumors in different primary sites].
    Khmelevsky EV; Bychkova NM
    Vopr Onkol; 2015; 61(1):77-84. PubMed ID: 26016150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of local recurrence in breast cancer after postmastectomy radiotherapy.
    Dunst J; Steil B; Furch S; Fach A; Lautenschläger C; Diestelhorst A; Lampe D; Kölbl H; Richter C
    Strahlenther Onkol; 2001 Oct; 177(10):504-10. PubMed ID: 11680014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A laboratory prognostic index model for patients with advanced non-small cell lung cancer.
    Ulas A; Turkoz FP; Silay K; Tokluoglu S; Avci N; Oksuzoglu B; Alkis N
    PLoS One; 2014; 9(12):e114471. PubMed ID: 25474743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stability, prognostic factors and survival of spinal bone metastases in malignant melanoma patients after palliative radiotherapy.
    Bostel T; Förster R; Schlampp I; Wolf R; Serras AF; Mayer A; Bruckner T; Welzel T; Schmidberger H; Debus J; Rief H
    Tumori; 2016; 102(2):156-61. PubMed ID: 26166220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiotherapy for painful bone metastases from hepatocellular carcinoma.
    Seong J; Koom WS; Park HC
    Liver Int; 2005 Apr; 25(2):261-5. PubMed ID: 15780048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of Patient-reported Symptoms Before Palliative Radiotherapy to Development of Multivariable Prognostic Models.
    Nieder C; Kämpe TA
    Anticancer Res; 2018 Mar; 38(3):1705-1709. PubMed ID: 29491105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.
    Touboul E; Buffat L; Belkacémi Y; Lefranc JP; Uzan S; Lhuillier P; Faivre C; Huart J; Lotz JP; Antoine M; Pène F; Blondon J; Izrael V; Laugier A; Schlienger M; Housset M
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):25-38. PubMed ID: 9989511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salvage Radiotherapy for Solitary Metachronous Bone Metastasis in Patients with Breast Cancer.
    Miyata M; Ohguri T; Yahara K; Yamaguchi S; Imada H; Korogi Y
    Anticancer Res; 2017 May; 37(5):2575-2579. PubMed ID: 28476829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors Associated with Long-Term Prostate Cancer Survival after Palliative Radiotherapy to a Bone Metastasis and Contemporary Palliative Systemic Therapy: A Retrospective, Population-Based Study.
    Venugopal B; Shahhat S; Beck J; Hanumanthappa N; Ong AD; Dubey A; Koul R; Bashir B; Chowdhury A; Sivananthan G; Kim JO
    Curr Oncol; 2023 Jun; 30(6):5560-5573. PubMed ID: 37366903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Palliative radiotherapy of bone metastases. A retrospective analysis of 176 patients].
    Koswig S; Buchali A; Böhmer D; Schlenger L; Budach V
    Strahlenther Onkol; 1999 Oct; 175(10):509-14. PubMed ID: 10554646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival after palliative radiotherapy in geriatric cancer patients.
    Nieder C; Angelo K; Haukland E; Pawinski A
    Anticancer Res; 2014 Nov; 34(11):6641-5. PubMed ID: 25368269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Radiotherapy of osseous metastases in breast cancer].
    Wagner W
    Geburtshilfe Frauenheilkd; 1991 Feb; 51(2):106-8. PubMed ID: 1710194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The importance of local-regional radiotherapy with conventional or high-dose chemotherapy in the management of breast cancer patients with > or = 10 positive axillary nodes.
    Jabro G; Wazer DE; Ruthazer R; Lum R; Sklar N; Goldman D; Enegess D; Erban J
    Int J Radiat Oncol Biol Phys; 1999 May; 44(2):273-80. PubMed ID: 10760419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiation Therapy for Patients with Bone Metastasis from Uterine Cervical Cancer: Its Role and Optimal Radiation Regimen for Palliative Care.
    Hata M; Koike I; Miyagi E; Asai-Sato M; Kaizu H; Mukai Y; Takano S; Ito E; Sugiura M; Inoue T
    Anticancer Res; 2018 Feb; 38(2):1033-1040. PubMed ID: 29374737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost of palliative radiation to the bone for patients with bone metastases secondary to breast or prostate cancer.
    Hess G; Barlev A; Chung K; Hill JW; Fonseca E
    Radiat Oncol; 2012 Oct; 7():168. PubMed ID: 23062178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer brain metastases at initial diagnosis.
    Leone JP; Leone J; Zwenger AO; Iturbe J; Leone BA; Vallejo CT
    Eur J Cancer; 2017 Mar; 74():17-25. PubMed ID: 28335884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stereotactic Body Radiotherapy (SBRT) for Spinal Metastases: Who Will Benefit the Most from SBRT?
    Park HJ; Kim HJ; Won JH; Lee SC; Chang AR
    Technol Cancer Res Treat; 2015 Apr; 14(2):159-67. PubMed ID: 24502552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Effect of Breast Cancer Subtype on Symptom Improvement Following Palliative Radiotherapy for Bone Metastases.
    Sit D; Zhao B; Chen KT; Lohrisch C; Olson R; Nichol A; Hsu F
    Clin Oncol (R Coll Radiol); 2022 Apr; 34(4):267-273. PubMed ID: 34690008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.